GH Relative Valuation - Guardant Health Inc

Watchlist Manager

Watchlist

Price: 86.2 USD 1.88% Market Closed

Market Cap: $11.3B

	Guardant Health Inc NASDAQ:GH	US

Multiples-Based Value

The Multiples-Based Value of one GH stock under the Base Case scenario is 44.82 USD. Compared to the current market price of 86.2 USD, Guardant Health Inc is Overvalued by 48%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

GH Multiples-Based Value

Base Case

Overvaluation 48%

Multiples-Based Value

Price $86.2

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Guardant Health Inc NASDAQ:GH	11.3B USD	11.5	-27.1	-29.6	-26.9
US		CVS Health Corp NYSE:CVS	89.1B USD	0.2	50.4	13.3	13.3
US	C	Cigna Group XMUN:CGN	66.9B EUR	0.3	12.9	7.6	9.7
US		Cigna Corp NYSE:CI	68B USD	0.2	11.4	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.1B EUR	1.1	19.9	9.4	14
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.2	23.4	9	16.7
US		Laboratory Corporation of America Holdings NYSE:LH	21.7B USD	1.6	24.7	11.9	17.2
US		Quest Diagnostics Inc NYSE:DGX	21.7B USD	2	22	11.9	16
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9B EUR	0.6	11.1	5.3	9.9
US		DaVita Inc NYSE:DVA	10.4B USD	0.8	14	7.2	9.8
US		Brightspring Health Services Inc NASDAQ:BTSG	8B USD	0	0	0	0

				Revenue Growth	P/S to Growth
US		Guardant Health Inc NASDAQ:GH	Average P/S: 1.9 11.5	29%	0.4
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.2	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		DaVita Inc NYSE:DVA	0.8	4%	0.2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	15%	N/A

				Earnings Growth	PEG
US		Guardant Health Inc NASDAQ:GH	Average P/E: 21.1 Negative Multiple: -27.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	50.4	90%	0.6
US	C	Cigna Group XMUN:CGN	12.9	19%	0.7
US		Cigna Corp NYSE:CI	11.4	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.4	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	24.7	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1	16%	0.7
US		DaVita Inc NYSE:DVA	14	20%	0.7
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	30%	N/A

				EBITDA Growth	EV/EBITDA to Growth
US		Guardant Health Inc NASDAQ:GH	Average EV/EBITDA: 9.5 Negative Multiple: -29.6	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	28%	0.5
US	C	Cigna Group XMUN:CGN	7.6	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.4	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.9	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		DaVita Inc NYSE:DVA	7.2	4%	1.8
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	31%	N/A

				EBIT Growth	EV/EBIT to Growth
US		Guardant Health Inc NASDAQ:GH	Average EV/EBIT: 13.3 Negative Multiple: -26.9	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.7	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.2	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.9	11%	0.9
US		DaVita Inc NYSE:DVA	9.8	5%	2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	43%	N/A

Guardant Health Inc
NASDAQ:GH

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GH Competitors Multiples
Guardant Health Inc Competitors

See Also

Company

Help

Tools

Stocks

Guardant Health Inc NASDAQ:GH

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GH Competitors Multiples Guardant Health Inc Competitors

See Also

Company

Help

Tools

Stocks

Guardant Health Inc
NASDAQ:GH

GH Competitors Multiples
Guardant Health Inc Competitors